Jove
Visualize
Contact Us

Related Experiment Videos

Cutaneous leishmaniasis.

N C Hepburn1

  • 1Dept. of Dermatology, Lincoln County Hospital, UK.

Clinical and Experimental Dermatology
|September 30, 2000
PubMed
Summary
This summary is machine-generated.

Leishmaniasis, a growing global health issue, can manifest as skin ulcers. Treatment for cutaneous leishmaniasis, especially forms caused by Leishmania braziliensis, involves systemic antimony, which is generally safe and effective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donepezil-induced linear IgA disease.

Clinical and experimental dermatology·2011
Same author

Xanthoma disseminatum with atypical histochemical features.

Clinical and experimental dermatology·2010
Same author

Cutaneous leishmaniasis: an overview.

Journal of postgraduate medicine·2003
Same author

Management of cutaneous leishmaniasis.

Current opinion in infectious diseases·2002
Same author

The management of cutaneous leishmaniasis from Belize.

Clinical and experimental dermatology·2001
Same author

Sertraline associated discoid lupus erythematosus-like eruption.

Journal of the Royal Army Medical Corps·1998
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
Same journal

Male genital fixed drug eruption: a systematic review.

Clinical and experimental dermatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Parasitology

Background:

  • Leishmaniasis is a significant and increasing global health concern.
  • Transmitted by sandflies, it causes diverse clinical syndromes, ranging from cutaneous ulcers to fatal systemic disease.
  • This review focuses on managing simple cutaneous leishmaniasis.

Purpose of the Study:

  • To review the management of simple cutaneous leishmaniasis.
  • To outline treatment protocols for lesions caused by Leishmania braziliensis.
  • To discuss the safety and efficacy of systemic antimony treatment.

Main Methods:

  • Review of current literature on leishmaniasis management.
  • Focus on clinical presentation and treatment of cutaneous leishmaniasis.

Related Experiment Videos

  • Evaluation of systemic antimony (sodium stibogluconate) as a first-line treatment.

    • Main Results:

    • Simple cutaneous leishmaniasis may heal spontaneously with minimal or no treatment.
    • Lesions caused by Leishmania braziliensis require systemic antimony treatment (sodium stibogluconate 20 mg/kg/day i.v. for 20 days).
    • Systemic antimony, despite potential transient side effects, is considered safe and effective.

    Conclusions:

    • Systemic antimony is the recommended first-line treatment for mucocutaneous leishmaniasis (espundia).
    • Treatment success should be assessed 6 weeks post-completion, with follow-up for 6 months.
    • Effective management and monitoring are crucial for favorable patient outcomes.